![Torben Lund-Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Torben Lund-Hansen
Profile
Torben Lund-Hansen currently works at Y-mAbs Therapeutics, Inc., as Chief Technology Officer & Senior Vice President from 2016.
Dr. Lund-Hansen also formerly worked at Medarex, Inc., as Director-Process Development, Genmab A, as Senior Vice President-Technical Operations, Genmab, Inc., as Senior Vice President-Technical Operations from 2002 to 2009, Novo Nordisk, Inc., as Principal, Genmab MN, Inc., as President & Treasurer from 2008 to 2009, and Lund-Hansen Consulting ApS, as Owner from 2009 to 2016.
Dr. Lund-Hansen received his graduate degree and doctorate degree from the University of Copenhagen.
Torben Lund-Hansen active positions
| Companies | Position | Start |
|---|---|---|
| YMAS THER | Chief Tech/Sci/R&D Officer | 01/01/2016 |
Former positions of Torben Lund-Hansen
| Companies | Position | End |
|---|---|---|
Lund-Hansen Consulting ApS | Corporate Officer/Principal | 01/01/2016 |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Chief Operating Officer | 01/01/2009 |
Genmab MN, Inc. | President | 01/01/2009 |
| GENMAB A/S | Corporate Officer/Principal | - |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Corporate Officer/Principal | - |
Training of Torben Lund-Hansen
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial physical and biological research services | Commercial Services |
Genmab A/S
 Genmab A/S Pharmaceuticals: MajorHealth Technology Develops differentiated antibody therapeutics for treatment of cancer | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Commercial Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Genmab MN, Inc. | |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. Develops novel antibody therapeutics for oncology targets | |
Lund-Hansen Consulting ApS |
- Stock Market
- Insiders
- Torben Lund-Hansen
